GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (XTER:ZEG) » Definitions » Shiller PE Ratio

AstraZeneca (XTER:ZEG) Shiller PE Ratio : 66.06 (As of May. 11, 2024)


View and export this data going back to 2001. Start your Free Trial

What is AstraZeneca Shiller PE Ratio?

As of today (2024-05-11), AstraZeneca's current share price is €144.00. AstraZeneca's E10 for the quarter that ended in Mar. 2024 was €2.18. AstraZeneca's Shiller PE Ratio for today is 66.06.

The historical rank and industry rank for AstraZeneca's Shiller PE Ratio or its related term are showing as below:

XTER:ZEG' s Shiller PE Ratio Range Over the Past 10 Years
Min: 4.62   Med: 23.7   Max: 75.22
Current: 66.95

During the past years, AstraZeneca's highest Shiller PE Ratio was 75.22. The lowest was 4.62. And the median was 23.70.

XTER:ZEG's Shiller PE Ratio is ranked worse than
85.85% of 530 companies
in the Drug Manufacturers industry
Industry Median: 25.165 vs XTER:ZEG: 66.95

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AstraZeneca's adjusted earnings per share data for the three months ended in Mar. 2024 was €1.288. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €2.18 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AstraZeneca Shiller PE Ratio Historical Data

The historical data trend for AstraZeneca's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Shiller PE Ratio Chart

AstraZeneca Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.82 35.15 52.72 71.22 59.93

AstraZeneca Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.34 66.74 65.79 59.93 57.80

Competitive Comparison of AstraZeneca's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, AstraZeneca's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Shiller PE Ratio falls into.



AstraZeneca Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AstraZeneca's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=144.00/2.18
=66.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, AstraZeneca's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.288/130.0000*130.0000
=1.288

Current CPI (Mar. 2024) = 130.0000.

AstraZeneca Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.464 99.800 0.604
201409 0.155 100.000 0.202
201412 -0.203 99.900 -0.264
201503 0.407 99.600 0.531
201506 0.490 100.100 0.636
201509 0.535 100.200 0.694
201512 0.578 100.400 0.748
201603 0.458 100.400 0.593
201606 -0.002 101.000 -0.003
201609 0.713 101.500 0.913
201612 1.375 102.200 1.749
201703 0.393 102.700 0.497
201706 0.338 103.500 0.425
201709 0.453 104.300 0.565
201712 0.870 105.000 1.077
201803 0.219 105.100 0.271
201806 0.231 105.900 0.284
201809 0.291 106.600 0.355
201812 0.721 107.100 0.875
201903 0.416 107.000 0.505
201906 0.080 107.900 0.096
201909 0.209 108.400 0.251
201912 0.216 108.500 0.259
202003 0.534 108.600 0.639
202006 0.515 108.800 0.615
202009 0.416 109.200 0.495
202012 0.641 109.400 0.762
202103 0.991 109.700 1.174
202106 0.349 111.400 0.407
202109 -0.935 112.400 -1.081
202112 -0.195 114.700 -0.221
202203 0.227 116.500 0.253
202206 0.218 120.500 0.235
202209 1.061 122.300 1.128
202212 0.548 125.300 0.569
202303 1.083 126.800 1.110
202306 1.080 129.400 1.085
202309 0.825 130.100 0.824
202312 0.569 130.000 0.569
202403 1.288 130.000 1.288

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AstraZeneca  (XTER:ZEG) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AstraZeneca Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca (XTER:ZEG) Business Description

Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.

AstraZeneca (XTER:ZEG) Headlines

No Headlines